Holen Sie sich die Stockscreener-App
2.22
0.89%
-0.02
Schlusskurs vom Vortag:
$2.24
Offen:
$2.25
24-Stunden-Volumen:
33,576
Relative Volume:
0.05
Marktkapitalisierung:
$10.07M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-128.28M
KGV:
-0.0362
EPS:
-61.2898
Netto-Cashflow:
$-5.26M
1W Leistung:
-7.88%
1M Leistung:
-25.50%
6M Leistung:
-62.21%
1J Leistung:
+0.00%
1-Tages-Spanne:
$2.15
$2.25
1-Wochen-Bereich:
$2.15
$2.4727
52-Wochen-Spanne:
$1.2104
$13.28
Lunai Bioworks Inc Stock (LNAI) Company Profile
Firmenname
Lunai Bioworks Inc
Sektor
Branche
Telefon
45 39179840
Adresse
CENTURY CITY MEDICAL PLAZA, SUITE 906 LOS ANGELES
Compare LNAI vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LNAI
Lunai Bioworks Inc
|
2.22 | 10.65M | 0 | -128.28M | -5.26M | -61.29 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Lunai Bioworks Inc Aktie (LNAI) Neueste Nachrichten
Why Is LNAI Stock Skyrocketing Today? - Stocktwits
Lunai Bioworks Ord Shs (LNAI) Earnings Forecast: Future EPS & Revenue Growth Estimates - tradingkey.com
Lunai Bioworks signs collaboration with BrainStorm Therapeutics - Investing.com
Lunai Bioworks files amended complaint alleging naked short selling - Investing.com
Lunai Bioworks signs collaboration with BrainStorm Therapeutics By Investing.com - Investing.com UK
Lunai Bioworks (Nasdaq: LNAI) Signs Definitive Collaboration Agreement With BrainStorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027 - 富途牛牛
Lunai Bioworks files amended complaint alleging naked short selling By Investing.com - Investing.com India
Lunai Bioworks (Nasdaq: LNAI) Names 10 Defendants in Naked Short Selling Fraud Suit - Yahoo Finance
Lunai Bioworks (LNAI) Declines 4.27%, Testing Key Support Near $1.92Dark Pool Sentiment - dars.gov.et
LNAI: Lunai Bioworks Inc.Financial Overview - Zacks Investment Research
LNAI|Lunai Bioworks Ord Shs|Price:2.240|Chg%:-0.090 - TradingKey
Lunai Bioworks Ord Shs (LNAI) Institutional Confidence - TradingKey
Lunai Bioworks Inc. Revenue Breakdown – NASDAQ:LNAI - TradingView
Lunai Bioworks Ord Shs (LNAI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lunai Bioworks(LNAI) Stock Options Chain | Quotes & News - Moomoo
Lunai Bioworks Inc. (LNAI) investor group discloses 9.41% stake in Schedule 13G - Stock Titan
Lunai Bioworks (LNAI) Tests Key Support After 3.4% DeclineReversal Setup Alerts - dars.gov.et
Lunai Bioworks Inc. (LNAI) Q2 2026 Earnings: Pre-Revenue Biotech Reports Narrowed Loss, Shares SlideEarnings Miss Streak - dars.gov.et
LNAI Q2 2026 Earnings: Biotech Reports Narrowing Loss, Shares Rise 7.1%Debt Analysis Report - dars.gov.et
Lunai Bioworks Q2 2026 Earnings: Loss of $0.08 Per Share as Stock Gains 7.1% on Pipeline Progress - dars.gov.et
RENB SEC FilingsRenovaro 10-K, 10-Q, 8-K Forms - Stock Titan
Lunai Bioworks (LNAI) Slides 9.7%: Key Support Levels in Focus After Sharp DeclineSmart Beta Flow - dars.gov.et
LUNAI BIOWORKS INC (LNAI) Stock Chart - ChartMill
Enterprise value to EBITDA forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Price to earnings forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Price to earnings forward of Lunai Bioworks, Inc. – FWB:2Q5 - TradingView
EBITDA per share of Lunai Bioworks, Inc. – FWB:2Q5 - TradingView
LNAI Should I Buy - Intellectia AI
Lunai Bioworks Inc. (LNAI) Q2 2026 Earnings: Modest Loss, Stock Gains on Pipeline OptimismEarnings Outlook Update - dars.gov.et
Lunai Bioworks (LNAI) Revenue BreakdownMain Composition - Moomoo
Enterprise value to EBIT forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Enterprise value to revenue forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Enterprise value to revenue forward of Lunai Bioworks, Inc. – LS:A42CL6 - TradingView
Price to book forward of Lunai Bioworks Inc. – NASDAQ:LNAI - TradingView
Price to book forward of Lunai Bioworks, Inc. – LS:A42CL6 - TradingView
Lunai Bioworks (LNAI) Stock Is Trending Overnight — Here's Why It Spiked Nearly 81% In After-Hours Session - MSN
Lunai Bioworks Inc. (NASDAQ: LNAI) Share Price, LNAI Stock News, LNAI Share Price & Updates - Kalkine
LNAI Q1 2026 Earnings: Lunai Bioworks Reports Loss While Stock Moves Higher on Pipeline OptimismMargin Expansion Trends - dars.gov.et
Lunai Bioworks Inc. (LNAI) Surges 10% as Bullish Momentum Builds Above Key SupportDividend Stock Picks - dars.gov.et
Lunai Bioworks Ord Shs (LNAI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LNAI Q1 2026 Earnings: Pre-Revenue Biotech Posts EPS of -$0.08, Stock Declines 5.5%Net Income Trends - po-news-eg.net
Lunai Bioworks Pursues Legal Action Over Alleged Manipulation - TipRanks
Lunai Bioworks (LNAI) Stock Jumps 81% After Nasdaq Compliance News - MEXC
Lunai Bioworks secures first revenue defense contract, files expedited discovery in naked shorting suit - TradingView
[8-K] Lunai Bioworks Inc. Reports Material Event - Stock Titan
Lunai Bioworks Ord Shs (LNAI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lunai Bioworks Ord Shs (LNAI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lunai Bioworks (LNAI) Stock Soars 81% on Nasdaq Compliance Restoration - MEXC
LNAI Stock Explodes On Volume As Traders Target Volatility - StocksToTrade
LUNAI BIOWORKS: CEO LETTER TO SHAREHOLDERS - The AI Journal
Lunai Bioworks (LNAI) Stock Soars 81% Following Nasdaq Compliance Restoration - parameter.io
Finanzdaten der Lunai Bioworks Inc-Aktie (LNAI)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):